Lei Xu
- Epidemiology top 2%
- Endocrinology, Diabetes and Metabolism top 2%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Surgery top 10%
- Topics
- Liver Disease Diagnosis and Treatment (36 papers)Gastric Cancer Management and Outcomes (18 papers)Colorectal Cancer Screening and Detection (18 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lei Xu
104 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Epidemiology 1.2k
- Endocrinology, Diabetes and Metabolism 598
- Molecular Biology 477
- Pathology and Forensic Medicine 447
- Surgery 366
Countries citing papers authored by Lei Xu
This map shows the geographic impact of Lei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Xu more than expected).
Fields of papers citing papers by Lei Xu
This network shows the impact of papers produced by Lei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Xu. The network helps show where Lei Xu may publish in the future.
Co-authorship network of co-authors of Lei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Lei Xu. A scholar is included among the top collaborators of Lei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Xu. Lei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 61 | |
| 9 | 4 | |
| 10 | 9 | |
| 11 | Dyslipidemia: Causes, Symptoms and Treatment | 3 |
| 12 | 3 | |
| 13 | 3 | |
| 14 | 0 | |
| 15 | 1 | |
| 16 | 20 | |
| 17 | 2 | |
| 18 | [Accuracy of procalcitonin for diagnosis of sepsis in adults: a Meta-analysis]. | 8 |
| 19 | 43 | |
| 20 | 47 |
About Lei Xu
Lei Xu is a scholar working on Epidemiology, Gastroenterology and Endocrinology, Diabetes and Metabolism, having authored 115 papers that have together received 2.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (36 papers), Gastric Cancer Management and Outcomes (18 papers) and Colorectal Cancer Screening and Detection (18 papers). The work is most often cited by research in Nephrology (349 citations), Endocrinology, Diabetes and Metabolism (598 citations) and Epidemiology (1.2k citations). Lei Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chaohui Yu, Chengfu Xu, Min Miao, Youming Li, Youming Li, Jiarong Xie, Han Ma, Hangkai Huang, Zhening Liu and Ruiqin Tan. Their work appears in journals such as The Journal of Experimental Medicine, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.